Which should be the first-line treatment for Helicobacter pylori in Colombia? A lesson from a recent study.
作者信息
Pellicano Rinaldo
机构信息
Unit of Gastroenterology, Molinette-SGAS Hospitals, Via Cavour 31, 10126 Turin, Turin 10123, Italy.
出版信息
Biomedica. 2019 Dec 1;39(4):811-815.
Abstract
摘要
相似文献
1
Which should be the first-line treatment for Helicobacter pylori in Colombia? A lesson from a recent study.哥伦比亚幽门螺杆菌的一线治疗应该是什么？一项近期研究的经验教训。
Biomedica. 2019 Dec 1;39(4):811-815.
2
Helicobacter pylori primary resistance to metronidazole and clarithromycin in Brazil.巴西幽门螺杆菌对甲硝唑和克拉霉素的原发性耐药性。
Antimicrob Agents Chemother. 2002 Jun;46(6):2021-3. doi: 10.1128/AAC.46.6.2021-2023.2002.
3
The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice?
Scand J Gastroenterol. 1995 May;30(5):401-7. doi: 10.3109/00365529509093298.
4
Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trial.铋剂四联疗法（使用含次水杨酸铋、甲硝唑和四环素的单粒胶囊并联合奥美拉唑）与奥美拉唑、阿莫西林和克拉霉素用于十二指肠溃疡患者根除幽门螺杆菌的疗效比较：一项前瞻性、随机、多中心北美试验。
Am J Gastroenterol. 2003 Mar;98(3):562-7. doi: 10.1111/j.1572-0241.2003.t01-1-07288.x.
5
A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.一项关于四联疗法和高剂量双联疗法治疗对甲硝唑和克拉霉素均耐药的幽门螺杆菌的前瞻性随机研究。
Helicobacter. 2003 Aug;8(4):310-9. doi: 10.1046/j.1523-5378.2003.00158.x.
6
Helicobacter pylori: Multiple resistance in patients from Bogotá, Colombia.幽门螺杆菌：哥伦比亚波哥大患者的多重耐药性
Biomedica. 2019 May 1;39(s1):125-134. doi: 10.7705/biomedica.v39i3.4437.
7
A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance.一项随机对照试验表明，在抗生素耐药率中等的人群中，14 天的混合疗法和铋四联疗法都能治愈大多数幽门螺杆菌感染患者。
Antimicrob Agents Chemother. 2017 Oct 24;61(11). doi: 10.1128/AAC.00140-17. Print 2017 Nov.
8
Clarithromycin-Based Triple Therapy is Still Useful as an Initial Treatment for Infection in the Dominican Republic.基于克拉霉素的三联疗法仍可用作多米尼加共和国感染的初始治疗方法。
Am J Trop Med Hyg. 2017 May;96(5):1050-1059. doi: 10.4269/ajtmh.16-0729. Epub 2017 Feb 13.
9
Antibiotic susceptibility patterns in Helicobacter pylori strains from patients with upper gastrointestinal pathology in western Nigeria.尼日利亚西部上消化道疾病患者幽门螺杆菌菌株的抗生素敏感性模式
Br J Biomed Sci. 2009;66(1):10-3. doi: 10.1080/09674845.2009.11730237.
10
[Failure in the eradication of Helicobacter pylori: the role of antibiotic resistance].[幽门螺杆菌根除失败：抗生素耐药性的作用]
Orv Hetil. 2005 May 1;146(18):839-42.
本文引用的文献
1
Helicobacter pylori: Multiple resistance in patients from Bogotá, Colombia.幽门螺杆菌：哥伦比亚波哥大患者的多重耐药性
Biomedica. 2019 May 1;39(s1):125-134. doi: 10.7705/biomedica.v39i3.4437.
2
Mutations in the Helicobacter pylori 23S rRNA gene associated with clarithromycin resistance in patients at an endoscopy unit in Medellín, Colombia.哥伦比亚麦德林一家内镜检查单位中，幽门螺杆菌23S rRNA基因的突变与患者对克拉霉素的耐药性相关。
Biomedica. 2019 Aug 1;39(Supl. 2):117-129. doi: 10.7705/biomedica.v39i4.4377.
3
Review: Treatment of Helicobacter pylori Infection 2019.综述：2019 年幽门螺杆菌感染的治疗。
Helicobacter. 2019 Sep;24 Suppl 1:e12640. doi: 10.1111/hel.12640.
4
Treating Helicobacter pylori infection in the face of growing antibiotic resistance.在面临抗生素耐药性不断增加的情况下治疗幽门螺杆菌感染。
Rev Esp Enferm Dig. 2019 Sep;111(9):653-654. doi: 10.17235/reed.2019.6575/2019.
5
Treatment of Helicobacter pylori.幽门螺杆菌治疗。
Curr Opin Gastroenterol. 2019 Nov;35(6):544-550. doi: 10.1097/MOG.0000000000000578.
6
Multidrug resistance in : current state and future directions.多药耐药性：现状与未来方向。
Expert Rev Clin Pharmacol. 2019 Sep;12(9):909-915. doi: 10.1080/17512433.2019.1654858. Epub 2019 Aug 28.
7
The analysis of virulence factors and antibiotic resistance between Helicobacter pylori strains isolated from gastric antrum and body.胃窦和胃体分离的幽门螺杆菌菌株毒力因子与耐药性分析。
BMC Gastroenterol. 2019 Aug 7;19(1):140. doi: 10.1186/s12876-019-1062-5.
8
Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition.日本幽门螺杆菌感染管理指南：2016 年修订版。
Helicobacter. 2019 Aug;24(4):e12597. doi: 10.1111/hel.12597. Epub 2019 May 20.
9
Helicobacter pylori: molecular basis for colonization and survival in gastric environment and resistance to antibiotics. A short review.幽门螺杆菌：在胃环境中定植和生存以及对抗生素耐药的分子基础。简短综述。
Infect Dis (Lond). 2019 Jun;51(6):399-408. doi: 10.1080/23744235.2019.1588472. Epub 2019 Mar 25.
10
Helicobacter pylori resistance to current therapies.幽门螺杆菌对现有疗法的耐药性。
Curr Opin Gastroenterol. 2019 Jan;35(1):6-13. doi: 10.1097/MOG.0000000000000497.
Zotero 插件